Related Experiment Video
Updated: Apr 28, 2026

02:52
Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
Published on: March 7, 2025
2.1K
Immediate and long-term consequences of vascular toxicity during zebrafish development
T L Tal1, C W McCollum2, P S Harris3
1Integrated Systems Toxicology Division, NHEERL, U.S. EPA, RTP, NC, United States.
Reproductive Toxicology (Elmsford, N.Y.)
|June 8, 2014
Summary
Environmental chemicals disrupt zebrafish vascular development, causing toxicity. Inhibitors targeting VEGFR2 and EGFR impaired blood vessel sprouting, leading to reduced growth and survival in juvenile fish.
Area of Science:
- Developmental toxicology
- Vascular biology
- Zebrafish models
Background:
- Vascular system formation is crucial for embryogenesis.
- Chemical disruption of vascular development can cause developmental toxicity.
- A quantitative assay is needed to assess environmental chemical effects on vascular development.
Purpose of the Study:
- To evaluate a quantitative assay in transgenic zebrafish for assessing the effects of environmental chemicals on vascular development.
- To investigate the impact of angiogenesis inhibitors targeting VEGFR2 (PTK787) and EGFR (AG1478) on vascular development in zebrafish.
Main Methods:
- Utilized transgenic zebrafish embryos.
- Administered angiogenesis inhibitors PTK787 (VEGFR2 inhibitor) and AG1478 (EGFR inhibitor).
- Quantitatively assessed intersegmental vessel (ISV) sprouting and fin development.
Main Results:
- Both PTK787 and AG1478 exposure impaired ISV sprouting.
- AG1478 caused caudal and pectoral fin defects at sub-morphogenesis-blocking concentrations.
- Developmental exposure to inhibitors resulted in decreased body length and survival in juvenile zebrafish.
Conclusions:
- Concentration-dependent disruption of VEGFR2 and EGFR targets by environmental chemicals leads to adverse outcomes.
- The zebrafish assay effectively models chemical-induced vascular toxicity with functional consequences.
- This study highlights the link between early-life vascular disruption and later-life health effects.

